IgG4 (mg/dL) |
33.9 (25.73; 67.8) |
159.5 (143.78; 174.93) |
<0.001 |
Total IgG (g/L) |
11.25 (10.31; 12.4) |
11.39 (10.69; 14.58) |
0.411 |
Age (years) |
39.96 ± 13.44 |
38.83 ± 11.84 |
0.844 |
Gender (% of males) |
14 (25.93%) |
1 (16.67%) |
1 |
TSH (μIU/mL) |
0.01 (0.01; 1.33) |
1.54 (0.34; 1.94) |
0.095 |
fT3 (pmol/L) |
10.78 (4.74; 26.2) |
6.06 (4.93; 6.76) |
0.498 |
fT4 (pmol/L) |
30.16 (15.4; 53.4) |
15 (13.18; 18.33) |
0.112 |
TRAb (IU/I) |
6.03 (2.56; 16.82) |
2.68 (1.54; 3.56) |
0.078 |
TPOAb (IU/mL) |
122.5 (31.25; 281) |
218 (154.5; 280.75) |
0.538 |
TgAb (IU/mL) |
71 (13; 325) |
246 (84.5; 554.5) |
0.204 |
CRP (mg/dL) |
6.03 (2.56; 16.82) |
2.68 (1.54; 3.56) |
0.408 |
Creatinine (mg/mL) |
0.57 (0.44; 0.73) |
0.62 (0.57; 0.73) |
0.267 |
ALT (U/I) |
23.5 (17.25; 32) |
24.5 (17.25; 28.75) |
0.970 |
AST (U/I) |
21.5 (16; 25) |
22.5 (20.25; 26.25) |
0.330 |
WBC (×103/μL) |
6.46 ± 1.75 |
6.35 ± 2.3 |
0.878 |
RBC (×106/μL) |
4.71 ± 0.4 |
4.76 ± 0.18 |
0.802 |
Hemoglobin (g/mL) |
13.55 (12.63; 14.38) |
14.1 (13.6; 14.38) |
0.810 |
PLT (×103/μL) |
4.71 ± 0.4 |
4.76 ± 0.18 |
0.802 |
Thyroid volume (cm3) |
29.82 ± 21.83 |
19.35 ± 15.25 |
0.233 |
Intrathyroidal blood flow |
1 (0; 2) |
1 (0.25; 1.75) |
0.707 |
Thyroid echogenicity |
1 (1; 2) |
1 (1; 1.75) |
0.792 |
Presence of any thyroid nodule (% of patients) |
36.73 |
16.67 |
0.653 |
Presence of multiple (≥3) thyroid nodules (% of patients) |
18.37 |
0 |
0.574 |
Moderate-to-severe GO (% of patients) |
14.81 |
66.67 |
0.012 |